Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-28 @ 11:10 PM
Study NCT ID:
NCT04205903
Status:
COMPLETED
Last Update Posted:
2025-06-29
First Post:
2019-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-18
First Submit QC Date:
None
Study First Post Date:
2019-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-16
Results First Submit QC Date:
None
Results First Post Date:
2025-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-16
Last Update Post Date:
2025-06-29
Last Update Post Date Type:
ACTUAL